EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade

Youngjin Choi, Su Hyun Seok, Hong Yeol Yoon, Ju Hee Ryu, Ick Chan Kwon

Advanced Drug Delivery Reviews · 2024-06 · 209 · 115306

DOI: 10.1016/j.addr.2024.115306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2024-06. Verfasst von Youngjin Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea. Hauptthemen laut MEDLINE: RNA, Small Interfering, Neoplasms, Immunotherapy, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Health Industry Development Institute, Ministry of Science, ICT and Future Planning, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingNeoplasmsImmunotherapyImmune Checkpoint InhibitorsGene SilencingHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

Cancer ImmunotherapyCombination therapyGene silencingImmune checkpoint blockadeNanoparticlesiRNA

Substanzen

RNA, Small InterferingImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea.
  • Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea; Division of Bio-Medical Science &Technology, KIST School, University…
  • Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea. Electronic address: jhryu@kist.re.kr.
  • Medicinal Materials Research Center, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Republic of Korea; KU-KIST Graduate School of Converging Science and Technology, Korea U…

Förderung

  • Korea Health Industry Development Institute
  • Ministry of Science, ICT and Future Planning
  • Ministry of Health and Welfare
  • National Research Foundation of Korea
  • Korea Institute of Science and Technology

Zitieren

APA

Choi, Y., Seok, S. H., Yoon, H. Y., Ryu, J. H., & Kwon, I. C. (2024). Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade. Advanced Drug Delivery Reviews, 209, 115306. https://doi.org/10.1016/j.addr.2024.115306

Vancouver

Choi Y, Seok SH, Yoon HY, Ryu JH, Kwon IC. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade. Advanced Drug Delivery Reviews. 2024;209:115306. doi:10.1016/j.addr.2024.115306

BibTeX
@article{Choi2024,
  author = {Choi, Youngjin and Seok, Su Hyun and Yoon, Hong Yeol and Ryu, Ju Hee and Kwon, Ick Chan},
  title = {Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade},
  journal = {Advanced Drug Delivery Reviews},
  year = {2024},
  volume = {209},
  pages = {115306},
  doi = {10.1016/j.addr.2024.115306}
}
Kostenlos starten →